Related Experiment Video
Updated: Jul 14, 2026
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones
Published on: November 30, 2016
Interferon-beta inhibits liver metastases from murine colon 26 carcinoma and its highly metastatic variant
Shigechika Kohashi1, Yuji Sato, Tsuyoshi Fukushima
1Department of Gastroenterological and General Surgery, Hokkaido University School of Medicine, N15-W7 Kita-ku, Sapporo, 060-8638, Japan.
Purpose:
The antitumor effects of Interferon-beta (IFN-beta) are due to its direct inhibition of cell proliferation, immunostimulatory activity, and the inhibition of angiogenesis. We investigated the mechanism of the effects of IFN-beta on a murine colon 26 cell line (CT 26) and its highly metastatic variant (L5).
Methods:
We examined its inhibitory effects on cell proliferation in vitro and the development of liver metastases in vivo.
Results:
The proliferation of CT 26 in vitro was inhibited by IFN-beta in a dose- and time-dependent manner. The number of metastases was reduced in mice inoculated with CT 26 (P<0.01) and L5 (P<0.01) on Day 14 after treatment with IFN-beta. The median survival rate of the mice inoculated with L5 administered IFN-beta every other day, or every day was higher than in the control group (P<0.05). A dorsal air sac assay demonstrated that IFN-beta inhibited angiogenesis in mice inoculated with CT 26, but the effects disappeared with aminoguanidine, an inducible nitric oxide synthase inhibitor.
Conclusion:
These results showed that IFN-beta directly inhibits the proliferation of CT 26. In addition, the in vivo experiments suggested that IFN-beta might effectively inhibit liver metastases.
Insights
Interferon-beta (IFN-beta) effectively inhibits colon cancer cell proliferation and reduces liver metastases in mice. This study investigated the mechanisms behind IFN-beta
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Interferon-beta (IFN-beta) exhibits antitumor properties through direct proliferation inhibition, immune stimulation, and anti-angiogenesis.
- Understanding the precise mechanisms of IFN-beta's action is crucial for optimizing cancer therapy.
Purpose of the Study:
- To investigate the mechanism of Interferon-beta (IFN-beta) effects on murine colon 26 (CT 26) cells and its highly metastatic variant (L5).
- To evaluate the inhibitory effects of IFN-beta on cell proliferation in vitro and liver metastasis development in vivo.
Main Methods:
- In vitro assessment of IFN-beta's inhibitory effects on CT 26 cell proliferation.
- In vivo evaluation of liver metastasis development in mice inoculated with CT 26 and L5 cells following IFN-beta treatment.
- Dorsal air sac assay to assess IFN-beta's impact on angiogenesis, with and without aminoguanidine.
Main Results:
- IFN-beta demonstrated dose- and time-dependent inhibition of CT 26 cell proliferation in vitro.
- Significant reduction in liver metastases was observed in mice treated with IFN-beta for both CT 26 and L5 cells (P<0.01).
- IFN-beta treatment led to increased median survival rates in mice with L5 cell-induced tumors (P<0.05) and inhibited angiogenesis.
Conclusions:
- IFN-beta directly inhibits the proliferation of CT 26 colon cancer cells.
- In vivo findings suggest that IFN-beta is a potential therapeutic agent for inhibiting liver metastases.
- The anti-angiogenic effect of IFN-beta may be linked to nitric oxide pathways.
